US4462943A
(en)
|
1980-11-24 |
1984-07-31 |
E. R. Squibb & Sons, Inc. |
Carboxyalkyl amino acid derivatives of various substituted prolines
|
DE3273628D1
(en)
|
1981-08-03 |
1986-11-13 |
Squibb & Sons Inc |
Phosphonamidate compounds
|
DE3360065D1
(en)
|
1982-03-08 |
1985-03-28 |
Schering Corp |
Carboxyalkyl dipeptides, processes for their production and pharmaceutical compositions containing them
|
US4514391A
(en)
|
1983-07-21 |
1985-04-30 |
E. R. Squibb & Sons, Inc. |
Hydroxy substituted peptide compounds
|
US4560506A
(en)
|
1984-05-25 |
1985-12-24 |
E. R. Squibb & Sons, Inc. |
Mercaptocycloalkylcarbonyl and mercaptoarylcarbonyl dipeptides
|
AU578489B2
(en)
|
1984-09-12 |
1988-10-27 |
Rorer Pharmaceutical Corporation |
Proline derivatives
|
JPS61148198A
(ja)
|
1984-12-22 |
1986-07-05 |
Ajinomoto Co Inc |
新規トリペプチド化合物および甘味剤
|
JPS6259296A
(ja)
|
1985-09-10 |
1987-03-14 |
Green Cross Corp:The |
ペプタイド誘導体
|
EP0254032A3
(en)
|
1986-06-20 |
1990-09-05 |
Schering Corporation |
Neutral metalloendopeptidase inhibitors in the treatment of hypertension
|
EP0566157A1
(en)
|
1986-06-20 |
1993-10-20 |
Schering Corporation |
Neutral metalloendopeptidase inhibitors in the treatment of hypertension
|
US4849525A
(en)
|
1987-09-21 |
1989-07-18 |
E. R. Squibb & Sons, Inc. |
Phosphinylcycloalkylcarbonyl and phosphinylcycloalkenylcarbonyl dipeptides
|
US5120859A
(en)
|
1989-09-22 |
1992-06-09 |
Genentech, Inc. |
Chimeric amino acid analogues
|
FR2700166B1
(fr)
|
1993-01-07 |
1995-02-17 |
Rhone Poulenc Rorer Sa |
Dérivés de pyrrolidine, leur préparation et les médicaments les contenant.
|
SK56296A3
(en)
|
1993-11-09 |
1997-02-05 |
Merck & Co Inc |
Piperidinal, pyrrolidinal and hexahydro-1h-azepinal derivatives, manufacturing process thereof and pharmaceutical compositions containing them
|
DE4408531A1
(de)
|
1994-03-14 |
1995-09-28 |
Hoechst Ag |
PNA-Synthese unter Verwendung einer gegen schwache Säuren labilen Amino-Schutzgruppe
|
GB9409150D0
(en)
|
1994-05-09 |
1994-06-29 |
Black James Foundation |
Cck and gastrin receptor ligands
|
US5491164A
(en)
|
1994-09-29 |
1996-02-13 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
AU2722297A
(en)
|
1996-04-03 |
1997-10-22 |
Merck & Co., Inc. |
Piperidines, pyrrolidines and hexahydro-1h-azepines promote release of growth hormone
|
DK0927161T3
(da)
|
1996-08-28 |
2003-02-17 |
Procter & Gamble |
Substitueret cyklisk amin-metalloproteaseinhibitorer
|
AU4342097A
(en)
|
1996-09-13 |
1998-04-02 |
Merck & Co., Inc. |
Piperidines, pyrrolidines and hexahydro-1h-azepines promote release of growth hormone
|
EA001915B1
(ru)
|
1996-10-18 |
2001-10-22 |
Вертекс Фармасьютикалз Инкорпорейтед |
Ингибиторы серин-протеаз, в частности ns3 протеазы вируса гепатита c (hvc)
|
WO1998025897A1
(en)
|
1996-12-12 |
1998-06-18 |
Merck & Co., Inc. |
Piperidines, pyrrolidines and hexahydro-1h-azepines promote release of growth hormone
|
US6864250B1
(en)
|
1997-08-22 |
2005-03-08 |
Kaken Pharmaceutical Co., Ltd. |
N-acylated lipophilic amino acid derivatives
|
US6399629B1
(en)
|
1998-06-01 |
2002-06-04 |
Microcide Pharmaceuticals, Inc. |
Efflux pump inhibitors
|
US6242422B1
(en)
|
1998-10-22 |
2001-06-05 |
Idun Pharmacueticals, Inc. |
(Substituted)Acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases
|
AU773227B2
(en)
|
1999-07-28 |
2004-05-20 |
Aventis Pharmaceuticals Inc. |
Substituted oxoazaheterocyclyl compounds
|
US6552016B1
(en)
|
1999-10-14 |
2003-04-22 |
Curis, Inc. |
Mediators of hedgehog signaling pathways, compositions and uses related thereto
|
IL148972A0
(en)
|
1999-10-14 |
2002-11-10 |
Curis Inc |
Mediators of hedgehog signaling pathways, compositions and uses related thereto
|
JP2003535034A
(ja)
|
1999-11-12 |
2003-11-25 |
ギルフォード ファーマシューティカルズ インコーポレイテッド |
ジペプチジルペプチダーゼiv阻害剤並びにジペプチジルペプチダーゼiv阻害剤の製造及び使用法
|
CA2385659C
(en)
|
2000-02-23 |
2011-04-19 |
Zealand Pharmaceuticals A/S |
Novel antiarrhythmic peptides
|
JP2003529594A
(ja)
|
2000-03-31 |
2003-10-07 |
ブリストル−マイヤーズ スクイブ ファーマ カンパニー |
Aβタンパク質産生の阻害剤としてのサクシノイルアミノ複素環
|
AU2001253633A1
(en)
|
2000-04-17 |
2001-10-30 |
Idun Pharmaceuticals, Inc. |
Inhibitors of the ice/ced-3 family of cysteine proteases
|
AU2000249828A1
(en)
|
2000-05-03 |
2001-11-12 |
Taisho Pharmaceutical Co. Ltd. |
Stat4 and stat6 binding dipeptide derivatives
|
EP1294752A2
(en)
|
2000-06-16 |
2003-03-26 |
Curis, Inc. |
Angiogenesis-modulating compositions and uses
|
JP2004504407A
(ja)
|
2000-07-21 |
2004-02-12 |
コルバス・インターナショナル・インコーポレイテッド |
C型肝炎ウイルスのns3−セリンプロテアーゼ阻害剤としての新規ペプチド
|
US7244721B2
(en)
|
2000-07-21 |
2007-07-17 |
Schering Corporation |
Peptides as NS3-serine protease inhibitors of hepatitis C virus
|
KR100939155B1
(ko)
|
2000-07-21 |
2010-01-28 |
쉐링 코포레이션 |
C형 간염 바이러스의 ns3-세린 프로테아제 억제제로서의신규한 펩티드
|
AR029851A1
(es)
|
2000-07-21 |
2003-07-16 |
Dendreon Corp |
Nuevos peptidos como inhibidores de ns3-serina proteasa del virus de hepatitis c
|
EP1387674B1
(en)
|
2000-10-13 |
2017-01-18 |
Curis, Inc. |
Hedgehog antagonists, methods and uses related thereto
|
US6376514B1
(en)
|
2000-10-17 |
2002-04-23 |
The Procter & Gamble Co. |
Substituted six-membered heterocyclic compounds useful for treating multidrug resistance and compositions and methods thereof
|
FR2816838B1
(fr)
|
2000-11-17 |
2004-12-03 |
Oreal |
Utilisation de derives de l'acide 2-oxothiazolidine- 4-carboxylique comme agents prodesquamants
|
IL157447A0
(en)
|
2001-02-22 |
2004-03-28 |
Zealand Pharma As Zealand Phar |
New medical uses of intercellular communication facilitating compounds
|
AU2002305450A1
(en)
|
2001-05-08 |
2002-11-18 |
Yale University |
Proteomimetic compounds and methods
|
EP1425029A4
(en)
|
2001-08-10 |
2006-06-07 |
Palatin Technologies Inc |
PEPTIDOMIMETICS OF BIOLOGICALLY ACTIVE METALLOPEPTIDES
|
CA2473070C
(en)
|
2002-01-23 |
2009-10-13 |
Schering Corporation |
Proline compounds as ns3-serine protease inhibitors for use in treatment of hepatites c virus infection
|
EP1480999A2
(en)
|
2002-02-08 |
2004-12-01 |
Idun Pharmaceuticals |
(substituted)acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases
|
CN100384819C
(zh)
|
2002-07-02 |
2008-04-30 |
诺瓦提斯公司 |
与细胞凋亡蛋白抑制剂结合的smac蛋白的肽抑制剂
|
WO2004020599A2
(en)
|
2002-08-29 |
2004-03-11 |
Curis, Inc. |
Hedgehog antagonists, methods and uses related thereto
|
WO2004045518A2
(en)
|
2002-11-15 |
2004-06-03 |
Bristol-Myers Squibb Company |
Open chain prolyl urea-related modulators of androgen receptor function
|
ZA200503600B
(en)
|
2002-11-25 |
2006-08-30 |
Zealand Pharma As |
Peptide gap junction modulators
|
EP1720844B1
(de)
|
2003-04-03 |
2009-04-29 |
MERCK PATENT GmbH |
Pyrrolidin-1,2-dicarbonsäure-1-(phenylamid)-2-(4-(3-oxo-morpholin-4-yl)-phenylamid) derivate und verwandte verbindungen als inhibitoren des koagulationsfaktors xa zur behandlung von thromboembolischen erkrankungen
|
US20040229848A1
(en)
|
2003-05-05 |
2004-11-18 |
Hans-Ulrich Demuth |
Glutaminyl based DP IV-inhibitors
|
MXPA06003963A
(es)
|
2003-10-14 |
2006-08-25 |
Intermune Inc |
Acidos carboxilicos macrociclicos y acilsulfonamidas como inhibidores de replicacion del hcv.
|
CN1528745A
(zh)
|
2003-10-21 |
2004-09-15 |
山东大学 |
吡咯烷类基质金属蛋白酶抑制剂及其制备方法
|
EP1742914A1
(en)
|
2004-02-27 |
2007-01-17 |
Schering Corporation |
Cyclobutenedione groups-containing compounds as inhibitors of hepatitis c virus ns3 serine protease
|
DK2653465T3
(da)
|
2004-03-15 |
2016-08-22 |
Janssen Pharmaceutica Nv |
Opioid-receptormodulatorer
|
JP4950026B2
(ja)
|
2004-03-30 |
2012-06-13 |
インターミューン・インコーポレーテッド |
ウイルス複製阻害剤としての大環状化合物
|
EP1604977A1
(en)
|
2004-06-02 |
2005-12-14 |
Faust Pharmaceuticals |
CIS pyrrolidinyl derivatives and their uses
|
KR20070034119A
(ko)
|
2004-07-16 |
2007-03-27 |
길리애드 사이언시즈, 인코포레이티드 |
항바이러스 화합물
|
US7820699B2
(en)
|
2005-04-27 |
2010-10-26 |
Hoffmann-La Roche Inc. |
Cyclic amines
|
AU2006332945C1
(en)
|
2005-12-23 |
2013-02-28 |
Wyeth |
Modified lysine-mimetic compounds
|
AU2007322291A1
(en)
|
2006-10-13 |
2008-05-29 |
Reliant Pharmaceuticals, Inc. |
Treatment with antiarrhythmics and omega-3 fatty acids and a combination product thereof
|
WO2008058016A2
(en)
|
2006-11-02 |
2008-05-15 |
University Of Virginia Patent Foundation |
Ethoid-containing compounds, methods for preparing ethoid-containing compounds, and methods for use
|
EP2074087A2
(en)
|
2006-12-21 |
2009-07-01 |
Wyeth |
Synthesis of pyrrolidine compounds
|
WO2008079412A2
(en)
|
2006-12-22 |
2008-07-03 |
The Trustees Of Columbia University In The City Of New York |
Methods and compositions to treat arrhythmias
|
EP2212343A2
(en)
|
2007-07-15 |
2010-08-04 |
Zealand Pharma A/S |
Peptide gap junction modulators
|
WO2012088425A2
(en)
|
2010-12-22 |
2012-06-28 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Gap junction-enhancing agents for treatment of necrotizing enterocolitis and inflammatory bowel disease
|
KR20140026410A
(ko)
|
2011-03-15 |
2014-03-05 |
유니버시티 오브 유타 리서치 파운데이션 |
혈관 관련 황반병증 및 이의 증상을 진단 및 치료하는 방법
|
JP2015515282A
(ja)
|
2012-04-25 |
2015-05-28 |
エムユーエスシー ファウンデーション フォー リサーチ ディベロップメント |
創傷治癒および組織修復のための組成物および方法
|
US20160166637A1
(en)
|
2013-08-02 |
2016-06-16 |
Virginia Tech Intellectual Properties, Inc. |
Methods of treating a cancer through targeted disruption of alpha connexin 43-zonula occludens-1 (zo-1) interaction
|
CN106132201A
(zh)
*
|
2014-01-23 |
2016-11-16 |
阿克比治疗有限公司 |
用于治疗眼部疾病的组合物和方法
|
EA201790434A1
(ru)
*
|
2014-08-22 |
2017-07-31 |
Окленд Юнисервисиз Лимитед |
Модуляторы каналов
|
GB201512139D0
(en)
|
2015-07-10 |
2015-08-19 |
Zealand Pharma As |
Methods of treatment
|